Presented complete, an IHP 310 Module 4 case study on lithium-induced hypothyroidism in bipolar disorder: pathophysiology of both conditions, drug mechanisms, a medication review table, appropriate treatment, monitoring and references. Searches like "ihp 310 module 4 assignment", "ihp310 module 4 endocrine and neural case study" and "ihp 310 module 4 example" land here.
The IHP 310 Module 4 example, in full
Not a Relapse: A Case Study of Lithium-Induced Hypothyroidism in a 44-Year-Old Man With Bipolar Disorder
[Student Name]
Southern New Hampshire University
IHP 310: Pathophysiology and Pharmacology Concepts
Module Four Case Study
[Instructor Name]
[Date]
The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.
Not a Relapse: A Case Study of Lithium-Induced Hypothyroidism in a 44-Year-Old Man With Bipolar Disorder
The Patient Record
Mr. Adeyemi is a composite 44-year-old warehouse manager with bipolar I disorder, diagnosed after a manic episode at age 36. He has taken lithium carbonate for four years, with serum levels in the therapeutic range and no mood episodes in that time. Over the past three months he reports tiredness, feeling cold at work, constipation, a weight gain of 5 kilograms and a sense that his thinking is slow and his mood flat. His wife worries that depression is returning. On examination his skin is dry and his heart rate is 58. Laboratory tests show a thyroid stimulating hormone level of 11.8 mIU/L, well above the normal range, and a low free thyroxine. His lithium level is 0.7 mmol/L and his kidney function is normal. The tempting reading of this chart is bipolar depression; the laboratory results point instead to a drug-induced endocrine problem.
Bipolar Disorder and Lithium
Bipolar I disorder is a mood disorder defined by episodes of mania, often alternating with depression. Its biology involves disturbed regulation of neural circuits that govern mood, energy and sleep, with strong genetic influence. Lithium is one of the most effective long-term treatments, reducing both manic and depressive relapses and lowering suicide risk, and it is recommended as a first-line maintenance treatment (Yatham et al., 2018). Its precise mechanism is not fully known, but it affects intracellular signaling pathways, including inhibition of the enzymes inositol monophosphatase and glycogen synthase kinase 3, and appears to stabilize neuronal excitability. Lithium has a narrow therapeutic range, so blood levels and kidney function must be monitored.
How Lithium Affects the Thyroid
In health, a signal from the hypothalamus prompts the pituitary to secrete thyroid stimulating hormone, and that hormone drives the thyroid gland to produce and release thyroxine and triiodothyronine. Thyroid hormone then feeds back to reduce the upstream signals. Lithium is concentrated in the thyroid and inhibits the release of stored hormone, and it can also reduce iodine uptake and hormone synthesis. As hormone levels fall, the pituitary raises thyroid stimulating hormone. Many patients compensate, but some develop hypothyroidism. A meta-analysis found that clinical hypothyroidism was nearly six times more common in patients taking lithium than in those given placebo, and that thyroid stimulating hormone rose by an average of 4 units (McKnight et al., 2012). Mr. Adeyemi's high thyroid stimulating hormone with low free thyroxine is the classic pattern of primary hypothyroidism.
Why the Two Conditions Look Alike
Thyroid hormone sets the metabolic rate of nearly every tissue, including the brain. When it is low, metabolism slows: patients feel tired and cold, gain weight, become constipated and have a slow heart rate and dry skin. In the brain, low thyroid hormone causes slowed thinking, poor concentration and low mood. These features overlap heavily with depression, which also causes fatigue, weight change and psychomotor slowing. Clues pointing to hypothyroidism here are the physical signs, cold intolerance, dry skin, constipation and bradycardia, which are not typical of depression. The distinction matters because the treatments differ, and untreated hypothyroidism can itself worsen the course of bipolar disorder.
Lithium's Other Effects Worth Watching
The same meta-analysis that documented lithium's thyroid effect also describes other effects that belong in any review of a patient taking it. Lithium reduced the kidney's ability to concentrate urine by about 15 percent of the normal maximum, which can cause thirst and frequent urination, although the absolute risk of kidney failure requiring dialysis was small, about 0.5 percent of patients. It raised blood calcium and parathyroid hormone slightly, and patients taking it gained more weight than those given placebo (McKnight et al., 2012). For Mr. Adeyemi, these findings mean that his weight gain may have two causes, hypothyroidism and lithium itself, and that his next set of monitoring tests should include calcium as well as kidney and thyroid function. A health information professional reviewing lithium charts can check that all of these tests appear at the intervals the clinic's protocol requires, since gaps in monitoring are a common source of preventable harm with narrow-range drugs.
Medication Review
The table below reviews current and proposed medications.
Table 1
Medication Review for Mr. Adeyemi
| Medication | Mechanism | Judgment | Reason |
|---|---|---|---|
| Lithium carbonate | Mood stabilizer; modulates intracellular signaling | Appropriate; continue | Four years without episodes; level in range |
| Levothyroxine (proposed) | Synthetic thyroxine replaces missing hormone | Start | Overt hypothyroidism with symptoms |
| Antidepressant (not indicated) | Increases monoamine signaling | Avoid for now | Symptoms explained by hypothyroidism; antidepressants can trigger mania in bipolar disorder |
Treatment and Monitoring
Hypothyroidism is treated with levothyroxine, a synthetic form of thyroxine, with the dose adjusted to bring thyroid stimulating hormone into the reference range (Jonklaas et al., 2014). Lithium should usually continue, since it has kept him well for four years. Levothyroxine should be taken on an empty stomach, apart from calcium, iron and antacids, which reduce its absorption. Thyroid stimulating hormone should be rechecked about six to eight weeks after starting or changing the dose, and symptoms reviewed. Ongoing lithium monitoring should continue, including serum levels, kidney function and thyroid tests at regular intervals. If his mood remains low once thyroid levels are normal, his psychiatrist should then evaluate for bipolar depression.
What the Case Teaches a Clinic
Lithium's thyroid effect is common and well known, yet it can be missed when symptoms are attributed to the psychiatric illness. A clinic can prevent this by building thyroid testing into its lithium monitoring protocol, alongside levels and kidney tests, and by prompting clinicians to check thyroid function whenever a patient on lithium presents with fatigue or low mood. Such a protocol protects patients from being treated for the wrong condition.
Conclusion
Mr. Adeyemi's slowed thinking, fatigue and weight gain are not a relapse of bipolar depression but hypothyroidism caused by lithium, which inhibits thyroid hormone release. Understanding the pathophysiology of both conditions, and how lithium acts on the brain and the thyroid, leads to the right plan: continue lithium, start levothyroxine, avoid an unnecessary antidepressant and monitor thyroid function and lithium together.
References
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., & Sawka, A. M. (2014). Guidelines for the treatment of hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid, 24(12), 1670-1751. https://doi.org/10.1089/thy.2014.0028
McKnight, R. F., Adida, M., Budge, K., Stockton, S., Goodwin, G. M., & Geddes, J. R. (2012). Lithium toxicity profile: A systematic review and meta-analysis. The Lancet, 379(9817), 721-728. https://doi.org/10.1016/S0140-6736(11)61516-X
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., Alda, M., MacQueen, G., Milev, R. V., Ravindran, A., O'Donovan, C., McIntosh, D., Lam, R. W., Vazquez, G., Kapczinski, F., . . . Berk, M. (2018). Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disorders, 20(2), 97-170. https://doi.org/10.1111/bdi.12609
How this IHP 310 Module 4 example is structured
The case is built around a diagnostic trap, so the paper begins with the chart and the tempting wrong conclusion. It then explains bipolar disorder and lithium, followed by the thyroid's normal regulation and how lithium disrupts it. A section explains why hypothyroidism mimics depression. A table reviews each medication, and the recommendations cover treatment, drug interactions and a monitoring schedule. The paper ends with a note on what the case teaches a clinic about monitoring patients on lithium.
Get IHP 310 Module 4 written to your instructions
Upload the Module 4 case materials from IHP 310, your rubric and the chart you must review. A written analysis of that chart is returned within 24 to 48 hours, and the first sample costs nothing. The paper above is an original model document written by our desk, not a submitted student paper and not an official Southern New Hampshire University document.
IHP 310 Module 4 questions, answered
What does the IHP 310 Module 4 case study usually ask?
This module's case study commonly focuses on endocrine and neural drug treatment: students work through a patient record, describe what has gone wrong in each body system, name the drugs and how they act, and decide whether treatment fits. It often serves as practice for the final project's record analysis.
How does lithium cause hypothyroidism?
Lithium is concentrated in the thyroid gland and inhibits the release of thyroid hormones, and it can interfere with iodine uptake and hormone synthesis. The pituitary responds by raising thyroid stimulating hormone. In some patients the gland cannot compensate, and hypothyroidism develops.
Does hypothyroidism mean lithium must be stopped?
Usually not. Lithium-induced hypothyroidism is generally treated with levothyroxine while lithium is continued, because lithium is often the most effective mood stabilizer for the patient. The decision belongs to the prescriber and patient and depends on the whole clinical picture.